Alfresa Holdings Corporation
ARHCF - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$2.5B
Close$
$25.66
83.3% upside
Current Fair Value
83.3% upsideUndervalued by 83.3% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $2.50 Billion |
|---|---|
| Enterprise Value | $-159,563,697,156.00 |
| Annual dividend | $0.44 |
| Dividend yield | 2.87% |
| Earnings per Share | $231.68 |
| Beta | 0.08 |
| Outstanding Shares | 178,807,346 |
Return
| Return on Equity | 8.08% |
|---|---|
| Return on Assets | 2.60% |
| Return on Invested Capital | 11.05% |
Valuation & Multiples
| P/E Ratio | 11.14 |
|---|---|
| PEG | -22.05 |
| Price to Sales | 0.0 |
| Price to Book Ratio | 0.01 |
| Enterprise Value to Revenue | 0.08 |
| Enterprise Value to EBIT | 4.32 |
| Enterprise Value to Net Income | -5 |
| Total Debt to Enterprise | 0.12 |
| Debt to Equity | 0.06 |
Revenue Sources
No data
Last Earnings Call
Report Date
August 5, 2026
EPS Estimate
$0.21
Consensus analyst estimateRevenue Estimate
$4.74 B
Consensus analyst estimateNext Earnings Call
Expected Date
November 9, 2026
EPS Estimate
$0.19
Consensus analyst estimateRevenue Estimate
$5.02 B
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Alfresa Holdings Corporation
12,525 employees
CEO: Ryuji Arakawa
Alfresa Holdings Corporation, a Japanese company established in Tokyo in 2003, operates globally through its subsidiaries, specializing in the production, wholesale distribution, marketing, and international trade of pharmaceuticals, dia...